The posterior use of BMP-2 in cervical deformity surgery does not result in increased early complications: A prospective multicenter study

Study designProspective cohort study.ObjectivesTo describe the rate of short-term complications following the posterior use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in cervical deformity (CD) surgery.MethodsCD patients from 2013 to 2015 were enrolled in a prospective, multicenter database. Patients were divided into those receiving rhBMP-2 (BMP) and no rhBMP-2 (NOBMP). The relationship between BMP use, demographic variables surgical variables, radiographic parameters and complications was evaluated.ResultsA total of 100 patients (47 BMP, 53 NOBMP) were included. Follow-up time averaged 7.6 months (range 3-12 months). An average of 13.6mg of BMP was used per person with 1.49 mg per level. Compared with the NOBMP group, patients in the BMP group were older (P = .03). BMP was more commonly used in patients that and had longer prior fusions (6.0 vs 2.5, P < .01). There were no differences between groups with regards to a history of surgery, Charlson Comorbidity Index, estimated blood loss, operation time, fusion levels, and surgical approach. The maintenance of radiographic parameters at 6-month follow-up was similar. There were no differences in terms of total complication incidence, total complications per person, major complications per person or any specific complication. Linear regression and Pearson correlation analysis did not reveal any strong r2 values (r2 = 0.09, 0.08, 0.06) between the use of BMP and complications (major or operative).ConclusionsBMP use was not directly associated with an increased incidence of early complications in this prospective cohort of operative adult CD patients. Its use was associated with increased number of levels instrumented and fused

Population history and anthropogenetic analysis of the city of Salta

En el presente trabajo se realizó un análisis de la composición antropogenética de una muestra poblacional de la ciudad de Salta, proveniente de 223 donantes que concurrieron al Centro Privado de Hemoterapia de la ciudad, quienes firmaron un consentimiento informado y completaron sus datos genealógicos. Se determinó el origen de los linajes maternos y paternos y se tipificaron 12 marcadores autosómicos a fin de estimar la mezcla génica utilizando el programa ADMIX. Los linajes maternos americanos representaron el 93,75% de la muestra, los europeos el 3,85% y un 2,40% los originarios de África (L). El linaje paterno Q*M3, de origen americano, se encontró en un 17,1% de los individuos masculinos. La mezcla génica resultó en un aporte nativo del 50,02%, seguido por el aporte europeo (46,29%) y subsahariano (3,51%). Respecto a ciudades previamente estudiadas por nuestro equipo, Salta se destaca por poseer la mayor presencia nativa americana en su acervo génico. Se destaca la gran importancia de las migraciones intrarregionales por sobre las interregionales o las internacionales. Estos estudios abonan la idea de que no se debe considerar a la población argentina como un todo homogéneo, sino considerar su variabilidad.In the present study the genetic composition of Salta capital city was estimated in a population sample. A total of 223 non related blood-donors from the Centro Privado de Hemoterapia were included, who provided written informed consent and genealogical information. Twelve autosomal markers, GM allotypes, mtDNA and Y-chromosome continental origin were analysed; genetic admixture was estimated employing the ADMIX program. Autosomal markers show the presence of 50,02% for the Amerindian component, 46,29% for the European and 3,51% for the African component. Amerindians mitochondrial haplogroups represented a 93,75%, while the Europeans haplogroups represented a 3,85% and the Africans a 2,40%; 17,1% of males analysed exhibited the aboriginal variant Q*M3. The data were compared to those obtained previously in other cities, and the genetic admixture of Salta showed the highest values of Amerindian and African component. The intraregional immigration is much more remarkable than interregional or foreign immigration. These studies reinforce the idea that the Argentine population should not be considered as a homogeneus totality but variability must be taken into account.Fil: Di Fabio Rocca, Francisco. Universidad Maimónides. Área de Investigaciones Biomédicas y Biotecnológicas. Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Albeza, Maria Virginia. Universidad Nacional de Salta; ArgentinaFil: Postillone, María Bárbara. Universidad Maimónides. Área de Investigaciones Biomédicas y Biotecnológicas. Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Acreche, Noemi Estela. Universidad Nacional de Salta; ArgentinaFil: Lafage, Lucía. Universidad Maimónides. Área de Investigaciones Biomédicas y Biotecnológicas. Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico; ArgentinaFil: Parolin, María Laura. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Centro Nacional Patagónico; ArgentinaFil: Dejean, Cristina Beatriz. Universidad Maimónides. Área de Investigaciones Biomédicas y Biotecnológicas. Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico; ArgentinaFil: Carnese, Francisco Raul. Universidad Maimónides. Área de Investigaciones Biomédicas y Biotecnológicas. Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico; ArgentinaFil: Avena, Sergio Alejandro. Universidad Maimónides. Área de Investigaciones Biomédicas y Biotecnológicas. Centro de Estudios Biomédicos, Biotecnológicos, Ambientales y de Diagnóstico; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

International audienceThe aim of this study was to estimate the incidence of COVID-19 disease in the French national population of dialysis patients, their course of illness and to identify the risk factors associated with mortality. Our study included all patients on dialysis recorded in the French REIN Registry in April 2020. Clinical characteristics at last follow-up and the evolution of COVID-19 illness severity over time were recorded for diagnosed cases (either suspicious clinical symptoms, characteristic signs on the chest scan or a positive reverse transcription polymerase chain reaction) for SARS-CoV-2. A total of 1,621 infected patients were reported on the REIN registry from March 16th, 2020 to May 4th, 2020. Of these, 344 died. The prevalence of COVID-19 patients varied from less than 1% to 10% between regions. The probability of being a case was higher in males, patients with diabetes, those in need of assistance for transfer or treated at a self-care unit. Dialysis at home was associated with a lower probability of being infected as was being a smoker, a former smoker, having an active malignancy, or peripheral vascular disease. Mortality in diagnosed cases (21%) was associated with the same causes as in the general population. Higher age, hypoalbuminemia and the presence of an ischemic heart disease were statistically independently associated with a higher risk of death. Being treated at a selfcare unit was associated with a lower risk. Thus, our study showed a relatively low frequency of COVID-19 among dialysis patients contrary to what might have been assumed